We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $370M
1-Year Est. Return 97.79%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+97.79%
3 Year Est. Return
+201.58%
5 Year Est. Return
10 Year Est. Return
AUM
$175M
AUM Growth
+$11.7M
Cap. Flow
+$906K
Cap. Flow %
0.52%
Top 10 Hldgs %
37.76%
Holding
209
New
26
Increased
49
Reduced
95
Closed
18

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.62M
2
STE icon
Steris
STE
+$1.75M
3
PFE icon
Pfizer
PFE
+$970K
4
ROKU icon
Roku
ROKU
+$840K
5
STIP icon
iShares 0-5 Year TIPS Bond ETF
STIP
+$790K

Sector Composition

Rank Sector Weight
1 Healthcare 26.42%
2 Miscellaneous 22.03%
3 Technology 17.53%
4 Financials 8.13%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVDL
1
DELISTED
Avadel Pharmaceuticals
AVDL
$18M 10.28%
2,514,905
-79,855
-3% -$560K
AAPL icon
2
Apple
AAPL
$4.67T
$12.4M 7.1%
95,703
-18,344
-16% -$2.62M
ARWR icon
3
Arrowhead Research
ARWR
$12.2B
$6.31M 3.6%
155,620
-1,000
-0.6% -$33.1K
MSFT icon
4
Microsoft
MSFT
$3.71T
$5.07M 2.9%
21,156
-357
-2% -$85.7K
AMZN icon
5
Amazon
AMZN
$2.79T
$4.88M 2.79%
58,095
-1,506
-3% -$149K
VTI icon
6
Vanguard Morningstar Total Stock Market ETF
VTI
$688B
$4.88M 2.78%
+25,507
New +$4.92M
JPM icon
7
JPMorgan Chase
JPM
$953B
$4.28M 2.44%
31,909
-413
-1% -$52.3K
NVDA icon
8
NVIDIA
NVDA
$5.56T
$3.71M 2.12%
253,670
-13,460
-5% -$197K
LMBS icon
9
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.45B
$3.6M 2.05%
75,896
-3,502
-4% -$166K
GOOGL icon
10
Alphabet (Google) Class A
GOOGL
$4.14T
$2.98M 1.7%
33,760
-1,925
-5% -$183K
PFE icon
11
Pfizer
PFE
$162B
$2.76M 1.58%
53,893
-20,233
-27% -$970K
CVX icon
12
Chevron
CVX
$409B
$2.49M 1.42%
13,889
-558
-4% -$97.4K
ABBV icon
13
AbbVie
ABBV
$453B
$2.34M 1.34%
14,509
-29
-0.2% -$4.45K
TTD icon
14
Trade Desk
TTD
$6.78B
$2.21M 1.26%
49,335
-5,070
-9% -$257K
BX icon
15
Blackstone
BX
$102B
$2.19M 1.25%
29,493
-8,179
-22% -$706K
XAIR icon
16
Beyond Air
XAIR
$3.47M
$2.12M 1.21%
815
+3
+0.4% +$7.67K
IVV icon
17
iShares Core S&P 500 ETF
IVV
$889B
$1.99M 1.14%
+5,186
New +$2M
JNJ icon
18
Johnson & Johnson
JNJ
$663B
$1.87M 1.07%
10,600
+292
+3% +$50.4K
MRK icon
19
Merck
MRK
$371B
$1.81M 1.03%
16,329
-171
-1% -$17.5K
UNH icon
20
UnitedHealth
UNH
$356B
$1.74M 0.99%
3,283
-300
-8% -$159K
ITOT icon
21
iShares Core S&P Total US Stock Market ETF
ITOT
$97.6B
$1.69M 0.96%
+19,924
New +$1.7M
DDD icon
22
3D Systems Corp
DDD
$575M
$1.67M 0.95%
225,275
-34,000
-13% -$298K
CVS icon
23
CVS Health
CVS
$124B
$1.63M 0.93%
17,507
-3,320
-16% -$320K
QYLD icon
24
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.38B
$1.52M 0.87%
95,377
-5,478
-5% -$88.5K
GIS icon
25
General Mills
GIS
$20.5B
$1.51M 0.86%
18,033
-266
-1% -$21.7K

Similar funds

Wealth Effects's Q4 2022 Portfolio in Review

As of Q4 2022, Wealth Effects held 209 positions worth $175M, up 7.1% from $164M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Wealth Effects's Q4 2022 filing shows 26 new, 49 increased, 95 reduced and 18 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 25,507 shares worth $4.88M. The largest sale was Apple, an estimated $2.62M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Technology.

  • Wealth Effects's largest Q4 2022 buy was Vanguard Morningstar Total Stock Market ETF: 25,507 shares worth $4.88M.
  • Wealth Effects added most to Vanguard Short-Term Corporate Bond ETF in Q4 2022, an estimated $670K increase.
  • Wealth Effects's biggest Q4 2022 reduction was Apple, cutting an estimated $2.62M.
  • Wealth Effects fully exited Steris in Q4 2022, selling an estimated $1.75M.
  • Wealth Effects's ten largest holdings make up 38% of its $175M portfolio in Q4 2022.
  • Wealth Effects opened 26 new positions and closed 18 in Q4 2022.
  • Wealth Effects's portfolio value rose 7.1% quarter-over-quarter to $175M.

Based on Wealth Effects's 13F filing for Q4 2022, filed 2 Feb 2023.